- Baker M, and Jones TD. The Identification and Removal of Immunogenicity in Therapeutic Proteins. Curr. Opin. Drug Discovery Dev. 2007; (2007); 10(2): 219-227.
- Jaber A, and Baker M. Assessment of Immunogenicity of Different Interferon Beta-1a Formulations Using ex vivo Assays. J. Pharma. Biomed. Anal. 2007; 43(4): 1256-1261.
- Chester K.A., Baker M. and Mayer A. Overcoming the Immunologic Response to Foreign Enzymes in Cancer Therapy. Expert Rev. Clin. Immunol. 2005; 1(4), 549-559.
- Jones TD, Philips W, Smith BJ, Bamford CA, Nayee PA, Baglin TP, Gaston GSH, Baker MP. Identification and Removal of a CD4+ T Cell Epitope from the C1 Domain of Factor VIII. J Thrombosis and Haemostasis. 2005 May;3(5):991-1000.
- Jones TD, Hanlon M, Smith BJ, Heise CT, Nayee PD, Sanders DA, Hamilton A, Sweet C, Unitt E, Alexander G, Lo KM, Gillies SD, Carr FJ, Baker MP. The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection. J Interferon Cytokine Res. 2004 Sep; 24(9): 560-72.
|
Publications